Phenobarbital Versus Lorazepam for Management of Alcohol Withdrawal Syndrome: A Retrospective Cohort Study

Introduction  Annually, 500,000 episodes of alcohol withdrawal syndrome (AWS) are severe enough to require clinical attention. A symptom-triggered lorazepam regimen remains the standard of care for the management of hospitalized AWS patients. However, phenobarbital has also been shown to be an effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawa, Fadi, Gilbert, Linsey, Gilbert, Benjamin, Hereford, Vanessa, Hawa, Aya, Al Hillan, Alsadiq, Weiner, Mark, Albright, Jeremy, Scheidel, Caleb, Al-Sous, Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949711/
https://www.ncbi.nlm.nih.gov/pubmed/33728215
http://dx.doi.org/10.7759/cureus.13282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949711/
https://www.ncbi.nlm.nih.gov/pubmed/33728215
http://dx.doi.org/10.7759/cureus.13282

Ejemplares similares